GO:0000224 peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000224 describes the enzymatic activity that cleaves the bond between an N-acetyl-beta-D-glucosamine residue and an asparagine side chain in glycoproteins, releasing a free peptide with aspartate and an N-acetylglucosaminylamine derivative.
• This activity is also known as peptide:N-glycanase (PNGase), with well-characterized bacterial (PNGase F) and plant (PNGase A) enzymes, and a cytosolic eukaryotic homolog NGLY1.
• PNGase F from Elizabethkingia meningoseptica (formerly Flavobacterium meningosepticum) is a widely used reagent for deglycosylation of N-linked glycoproteins in proteomics and biopharmaceutical analysis.
• In eukaryotes, NGLY1-mediated deglycosylation is part of the endoplasmic reticulum-associated degradation (ERAD) pathway, helping to remove misfolded glycoproteins.
• Loss-of-function mutations in human NGLY1 cause NGLY1 deficiency, a rare neurodevelopmental disorder with developmental delay, hypotonia, and alacrima.
• The catalytic mechanism involves a conserved cysteine residue that acts as a nucleophile, forming a covalent enzyme-substrate intermediate.
Description
Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity, encoded by the Gene Ontology term GO:0000224, is a molecular function that catalyzes the hydrolysis of the amide bond between an N-acetyl-beta-D-glucosamine (GlcNAc) residue and the side-chain amide of an asparagine residue in glycoproteins. This reaction releases the intact peptide with an aspartate at the former glycosylation site and generates N-acetyl-beta-D-glucosaminylamine, which may carry additional sugar residues. The activity is widely known as peptide:N-glycanase (PNGase) and is essential for the study of protein glycosylation, as it allows the removal of N-linked glycans from glycoproteins. Researchers value this activity for both basic and applied purposes. In biotechnology and proteomics, PNGase F from Elizabethkingia meningoseptica is the gold-standard enzyme for deglycosylating therapeutic antibodies and other glycoproteins prior to mass spectrometry analysis. In cell biology, the eukaryotic PNGase ortholog NGLY1 plays a critical role in the endoplasmic reticulum-associated degradation (ERAD) pathway, where it removes N-glycans from misfolded glycoproteins to facilitate their proteasomal degradation. The importance of this activity is underscored by the discovery that mutations in human NGLY1 cause a severe neurodevelopmental disorder, highlighting its non-redundant physiological functions. Understanding GO:0000224 therefore spans enzymology, glycobiology, and human genetics. The availability of recombinant PNGase F and the characterization of its active site have made it a model enzyme for studying glycosidase mechanisms. Meanwhile, studies in model organisms such as Caenorhabditis elegans and mouse models have begun to reveal the cellular pathways that depend on NGLY1 activity. This article provides a comprehensive overview of the definition, mechanism, key genes, disease relevance, and research methods associated with peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity.
peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity At A Glance
| GO ID | GO:0000224 |
|---|---|
| GO term | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity |
| Ontology | molecular_function |
| Synonym | glycopeptidase activity; glycopeptide N-glycosidase activity; jack-bean glycopeptidase; N-glycanase activity; N-linked-glycopeptide-(N-acetyl-beta-D-glucosaminyl)-L-asparagine amidohydrolase activity; N-oligosaccharide glycopeptidase activity; peptide:N-glycanase; PNGase; PNGase A; PNGase F |
| Major function | Hydrolysis of the amide bond between N-acetyl-beta-D-glucosamine and asparagine in N-linked glycoproteins, releasing a free peptide with aspartate and an N-acetylglucosaminylamine derivative. |
| Substrates | N-linked glycoproteins and glycopeptides containing an N4-(acetyl-beta-D-glucosaminyl)asparagine residue. |
| Products | Peptide L-aspartate and N-acetyl-beta-D-glucosaminylamine (which may be further glycosylated). |
| Cofactors | No known cofactors required; the reaction uses water as a nucleophile. |
| Localization | In eukaryotes, NGLY1 is cytosolic; bacterial PNGase F is secreted or periplasmic; plant PNGase A is vacuolar. |
What Is GO:0000224?
In simple terms, GO:0000224 describes an enzyme that acts like a molecular pair of scissors, cutting the connection between a sugar chain (N-acetyl-beta-D-glucosamine) and the amino acid asparagine in a protein. The official definition states: Catalysis of the reaction: 4-N-(N-acetyl-D-glucosaminyl)-protein + H2O = N-acetyl-beta-D-glucosaminylamine + peptide L-aspartate. This reaction is the hydrolysis of an N4-(acetyl-beta-D-glucosaminyl)asparagine residue in which the N-acetyl-D-glucosamine residue may be further glycosylated, to yield a (substituted) N-acetyl-beta-D-glucosaminylamine and the peptide containing an aspartic residue. The activity is synonymous with glycopeptidase, glycopeptide N-glycosidase, jack-bean glycopeptidase, N-glycanase, peptide:N-glycanase (PNGase), PNGase A, and PNGase F.
Why Is peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity Important in Cell Biology?
Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity is fundamentally important because it provides a biochemical tool to remove N-linked glycans from glycoproteins, enabling detailed analysis of protein glycosylation, which is critical for understanding protein folding, stability, and function. In eukaryotic cells, the cytosolic PNGase NGLY1 is a key component of the ERAD pathway, where it processes misfolded glycoproteins for degradation, thereby maintaining proteostasis. Dysregulation of this activity has been linked to human disease, notably NGLY1 deficiency, a rare genetic disorder with severe neurological symptoms. Moreover, the activity is exploited in the biopharmaceutical industry for quality control of therapeutic glycoproteins, where PNGase F treatment is a standard step in glycan analysis.
• Enables deglycosylation of N-linked glycoproteins for mass spectrometry and structural studies.
• Plays a central role in ERAD by removing N-glycans from misfolded proteins to facilitate their degradation.
• Mutations in NGLY1 cause a neurodevelopmental disorder characterized by developmental delay, hypotonia, and alacrima.
• Provides a model system for studying enzyme mechanism, including covalent catalysis by a conserved cysteine.
• Used as a biopharmaceutical tool for quality control of therapeutic antibodies and other glycoproteins.
• Contributes to the catabolism of free oligosaccharides, and defects in related pathways cause neurodevelopmental disorders.
• Facilitates the study of plant glycoprotein processing during germination and development.
• Serves as a target for engineering enzymes with altered substrate specificity for glycoengineering applications.
Molecular Mechanism of peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs onto the sugar chain and the protein part of the glycoprotein.
Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase specifically recognizes N-linked glycoproteins that contain an N-acetyl-beta-D-glucosamine residue attached to an asparagine side chain. The enzyme binds to both the sugar moiety and the peptide backbone, with the oligosaccharide recognition involving multiple subsites that accommodate the branching and composition of the N-glycan. Studies on PNGase F from Elizabethkingia meningoseptica have identified residues that interact with the substrate, including those that form hydrogen bonds with the N-acetyl group of the GlcNAc and the asparagine amide.
Catalytic Mechanism and Covalent Intermediate
In simple terms: A cysteine in the enzyme's active site attacks the bond, forming a temporary link with the sugar, then water breaks it to release the products.
The catalytic mechanism of peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase involves a conserved cysteine residue that acts as a nucleophile. This cysteine attacks the carbonyl carbon of the asparagine side-chain amide, leading to the formation of a covalent enzyme-substrate intermediate and the release of ammonia. Subsequent hydrolysis of this intermediate by water yields the free peptide with aspartate and the N-acetyl-beta-D-glucosaminylamine product. Site-directed mutagenesis of PNGase F has confirmed the essential role of this cysteine, as its replacement abolishes enzymatic activity.
Product Release and Regeneration
In simple terms: After the reaction, the enzyme lets go of the products and is ready to act again.
Following the hydrolysis step, the enzyme releases the deglycosylated peptide and the N-acetyl-beta-D-glucosaminylamine moiety, which may still carry additional sugar residues. The enzyme returns to its resting state and can catalyze multiple rounds of deglycosylation. The reaction is dependent on water as a co-substrate, and no external energy source or cofactor is required.
Regulation and Cellular Context
In simple terms: Inside cells, the enzyme's activity is controlled by where it is located and by the availability of substrates.
In eukaryotic cells, the cytosolic PNGase NGLY1 is regulated at the level of gene expression and subcellular localization. Its activity is coupled to the ERAD pathway, where it acts after the retrotranslocation of misfolded glycoproteins from the endoplasmic reticulum into the cytosol. The activity of NGLY1 can be influenced by the presence of free oligosaccharides and by interactions with other ERAD components, though the precise regulatory mechanisms are still being elucidated. In plants, PNGase A activity is developmentally regulated during germination.
Key Genes Involved in GO:0000224 peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity
The following genes and proteins are directly associated with peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity or its biological context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NGLY1 | Cytosolic peptide:N-glycanase in eukaryotes; deglycosylates misfolded glycoproteins in ERAD | Mutations cause NGLY1 deficiency; model for neurodevelopmental disorders |
| PNGase F (from Elizabethkingia meningoseptica) | Bacterial peptide:N-glycanase; widely used as a deglycosylation reagent | Biotechnological tool for glycoprotein analysis; model for enzyme mechanism |
| PNGase A (from almond, Prunus dulcis) | Plant peptide:N-glycanase; deglycosylates plant and insect glycoproteins | Used for deglycosylation of plant and insect glycoproteins; studied during germination |
| ENGase (Endo-beta-N-acetylglucosaminidase) | Hydrolyzes the chitobiose core of N-glycans, leaving one GlcNAc attached | Complementary activity to PNGase; involved in free oligosaccharide catabolism |
| MAN2C1 | Alpha-mannosidase involved in free oligosaccharide catabolism | Defects cause neurodevelopmental disorder; related to NGLY1 pathway |
| Derlin-1 (DERL1) | ERAD component that retrotranslocates misfolded proteins | Interacts with NGLY1 in ERAD; potential target for modulating NGLY1 activity |
| VCP/p97 | AAA-ATPase that extracts misfolded proteins from the ER | Cooperates with NGLY1 in ERAD; mutations cause IBMPFD |
| HRD1 (SYVN1) | E3 ubiquitin ligase in ERAD | Ubiquitinates misfolded glycoproteins prior to NGLY1 action |
| SEL1L | ERAD adaptor protein | Forms complex with HRD1; involved in NGLY1-dependent degradation |
| UGGT1 | UDP-glucose:glycoprotein glucosyltransferase | Recognizes misfolded glycoproteins; part of the calnexin cycle upstream of NGLY1 |
| EDEM1 | ER degradation-enhancing alpha-mannosidase-like protein | Accelerates ERAD of misfolded glycoproteins; functional link to NGLY1 |
| OS-9 (OS9) | Lectin that targets misfolded glycoproteins for ERAD | Binds to N-glycans and facilitates NGLY1 substrate delivery |
| XTP3-B (ERLEC1) | Lectin involved in ERAD | Similar to OS-9; helps recruit substrates to NGLY1 |
| PNG1 (yeast) | Yeast peptide:N-glycanase | Model for studying NGLY1 function in a simple eukaryote |
| png-1 (C. elegans) | Caenorhabditis elegans peptide:N-glycanase | Genetic model for NGLY1 deficiency; reveals conserved roles |
| Ngly1 (mouse) | Mouse peptide:N-glycanase | Knockout mice show developmental defects; model for human disease |
| NGLY1 (human) | Human peptide:N-glycanase | Central to NGLY1 deficiency; target for therapeutic development |
How Is peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity Regulated?
The activity of peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase is regulated at multiple levels. In eukaryotes, the expression of NGLY1 is controlled transcriptionally, and its cytosolic localization is essential for its role in ERAD. The activity is also regulated by the availability of substrates, which are generated by the retrotranslocation of misfolded glycoproteins from the endoplasmic reticulum. Additionally, the activity can be influenced by interactions with other ERAD components such as VCP/p97 and Derlin-1, which help deliver substrates to NGLY1. In plants, PNGase A activity is developmentally regulated during seed germination, likely to process storage glycoproteins. Furthermore, the catabolism of free oligosaccharides, in which PNGase activity generates substrates for downstream enzymes like MAN2C1, is a regulated process, and its impairment leads to neurodevelopmental disorders.
peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NGLY1 | NGLY1 deficiency (neurodevelopmental disorder with alacrima, hypotonia, developmental delay) | Knockout cell lines (HEK293, iPSC-derived neurons); mouse Ngly1 KO; C. elegans png-1 mutants |
| MAN2C1 | Neurodevelopmental disorder due to impaired free oligosaccharide catabolism | MAN2C1 knockout cells; patient-derived fibroblasts; mouse models |
| PNGase F (bacterial) | Not a human disease gene; used as a tool in glycoprotein analysis | Recombinant expression in E. coli; site-directed mutagenesis for mechanistic studies |
| PNGase A (plant) | Not a human disease gene; involved in plant glycoprotein processing | Plant models (e.g., Raphanus sativus) during germination; recombinant expression |
| VCP/p97 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD) | Knockout and point-mutation cell models; patient-derived cells |
NGLY1 Deficiency: A Rare Neurodevelopmental Disorder
Biallelic loss-of-function mutations in the human NGLY1 gene cause NGLY1 deficiency, an autosomal recessive disorder characterized by developmental delay, hypotonia, alacrima (absence of tears), and a range of other neurological and systemic symptoms. The disease was first described in 2012 and has since been studied in various model organisms, including Caenorhabditis elegans and mouse, which recapitulate key aspects of the human phenotype. The pathophysiology is thought to involve impaired ERAD and accumulation of misfolded glycoproteins, though the exact mechanisms remain under investigation.
Role in ERAD and Protein Quality Control
Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity is a critical step in the endoplasmic reticulum-associated degradation (ERAD) pathway, which removes misfolded proteins from the secretory pathway. In this context, NGLY1 deglycosylates retrotranslocated glycoproteins, allowing them to be degraded by the proteasome. Defects in this process can lead to the accumulation of toxic protein aggregates, which are implicated in various neurodegenerative diseases. However, direct links between NGLY1 activity and common neurodegenerative disorders are still being explored.
Free Oligosaccharide Catabolism and MAN2C1-Related Disorder
The activity of peptide:N-glycanase generates free oligosaccharides that are further catabolized by enzymes such as MAN2C1. Mutations in MAN2C1 cause a neurodevelopmental disorder due to impaired catabolism of free oligosaccharides, highlighting the importance of the entire pathway in which PNGase activity participates. This suggests that disruptions in the generation or processing of free oligosaccharides can have severe neurological consequences.
From peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of NGLY1 loss on ERAD and protein aggregation? | NGLY1 knockout HEK293 or HeLa cells; mouse Ngly1 knockout |
| How does a specific point mutation in NGLY1 affect its enzymatic activity? | Point-mutation knock-in cell lines (e.g., catalytically dead C306A) |
| Can wild-type NGLY1 rescue the phenotype of NGLY1-deficient cells? | Knock-in of wild-type NGLY1 under endogenous promoter; overexpression |
| Where is NGLY1 localized in the cell and how does it interact with ERAD components? | Tagged knock-in (e.g., GFP or HA) for imaging and co-IP |
| What are the downstream consequences of PNGase F treatment on glycoprotein structure? | Overexpression of PNGase F in E. coli or mammalian cells; in vitro deglycosylation assays |
| How does NGLY1 deficiency affect neuronal development? | iPSC-derived neurons from NGLY1 patients; C. elegans png-1 mutants |
How to Study the peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| PNGase F digestion followed by SDS-PAGE | Shift in electrophoretic mobility due to deglycosylation | Assessing glycosylation status of purified proteins |
| Mass spectrometry (LC-MS/MS) | Mass of glycopeptides before and after PNGase treatment | Mapping N-glycosylation sites and glycan composition |
| Fluorescent substrate assays | Enzymatic activity using synthetic substrates | Kinetic characterization of PNGase variants |
| Site-directed mutagenesis | Effect of specific amino acid changes on activity | Identifying catalytic residues |
| Immunofluorescence microscopy | Subcellular localization of NGLY1 | Determining co-localization with ER markers |
| ERAD reporter assays | Degradation of misfolded model proteins | Measuring NGLY1-dependent ERAD activity |
| C. elegans png-1 mutant analysis | Developmental and behavioral phenotypes | Modeling NGLY1 deficiency |
| Mouse Ngly1 knockout | Physiological and neurological phenotypes | Preclinical testing of therapies |
Enzymatic Assays for PNGase Activity
The activity of peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase can be measured using synthetic glycopeptide substrates or denatured glycoproteins, followed by analysis of products by HPLC, mass spectrometry, or gel electrophoresis. Recombinant PNGase F is commercially available and is widely used as a standard. For mechanistic studies, site-directed mutagenesis of the catalytic cysteine and kinetic analyses are employed.
Proteomics and Glycoproteomics
PNGase F treatment is a standard step in glycoproteomics workflows to remove N-glycans from glycopeptides prior to mass spectrometry, enabling the identification of glycosylation sites and the characterization of glycan structures. This approach is essential for analyzing therapeutic glycoproteins and for biomarker discovery.
Cell-Based Assays for NGLY1 Function
To study the cellular role of NGLY1, researchers use knockout cell lines and RNA interference, combined with assays for ERAD efficiency, protein aggregation, and ER stress markers. Fluorescence microscopy of tagged NGLY1 allows visualization of its subcellular localization and dynamics.
Model Organism Studies
Caenorhabditis elegans png-1 mutants and mouse Ngly1 knockout models have been used to investigate the physiological consequences of NGLY1 deficiency, including developmental defects and neurological phenotypes. These models provide insights into the conserved functions of the enzyme and serve as platforms for testing therapeutic interventions.
How CRISPR Can Be Used to Study GO:0000224 peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity
Knockout
CRISPR-Cas9 knockout of NGLY1 in human cell lines (e.g., HEK293, HeLa) is used to study the loss of peptide:N-glycanase activity and its consequences for ERAD, protein aggregation, and cellular stress responses. Knockout models help validate the role of NGLY1 in these pathways and can be used to test rescue by wild-type or mutant NGLY1.
Point Mutation
Point mutations in the catalytic cysteine of NGLY1 (e.g., C306A) can be introduced using CRISPR-Cas9 homology-directed repair to create catalytically inactive knock-in cell lines. These models are valuable for dissecting the enzymatic versus non-enzymatic functions of NGLY1 and for understanding the impact of specific patient mutations.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) or fluorescent proteins at the endogenous NGLY1 locus allows real-time imaging and biochemical isolation of the enzyme. This approach is useful for studying NGLY1 localization, interactions, and dynamics in living cells.
Overexpression
Overexpression of NGLY1 or PNGase F in mammalian cells or E. coli is used to produce large amounts of enzyme for structural and biochemical studies, as well as to enhance deglycosylation capacity in bioprocessing. Overexpression models can also help identify dose-dependent effects on ERAD and cellular physiology.
How EDITGENE Supports peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity Research
Researchers studying peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation, from knockout to knock-in, in a variety of cell models.
Contact EDITGENE today to design your custom CRISPR model for peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity research.
Frequently Asked Questions About peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity
What is peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity?
It is an enzymatic activity, classified as GO:0000224, that removes N-linked glycans from glycoproteins by hydrolyzing the bond between N-acetyl-beta-D-glucosamine and asparagine, releasing a free peptide with aspartate and an N-acetylglucosaminylamine derivative.
What genes are involved in peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity?
The main genes include NGLY1 in humans, PNGase F in Elizabethkingia meningoseptica, PNGase A in plants, and orthologs such as PNG1 in yeast and png-1 in C. elegans.
What is the function of NGLY1?
NGLY1 encodes a cytosolic peptide:N-glycanase that removes N-glycans from misfolded glycoproteins in the ERAD pathway, facilitating their degradation by the proteasome.
What diseases are associated with NGLY1 mutations?
Mutations in NGLY1 cause NGLY1 deficiency, a rare neurodevelopmental disorder characterized by developmental delay, hypotonia, and alacrima.
How is PNGase F used in research?
PNGase F is widely used as a reagent to deglycosylate N-linked glycoproteins for mass spectrometry, structural studies, and quality control of therapeutic proteins.
What is the catalytic mechanism of peptide:N-glycanase?
The enzyme uses a conserved cysteine residue as a nucleophile to form a covalent intermediate with the substrate, followed by hydrolysis to release the products.
What is the difference between PNGase A and PNGase F?
PNGase A is a plant enzyme that can cleave a broader range of N-glycans, including those with core alpha-1,3-fucose, while PNGase F is a bacterial enzyme that cleaves most N-linked glycans except those with core alpha-1,3-fucose.
How can I study peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity in the lab?
Common methods include enzymatic assays with synthetic substrates, deglycosylation followed by SDS-PAGE or mass spectrometry, and cell-based assays using NGLY1 knockout or knockdown models.
What model organisms are used to study NGLY1?
Caenorhabditis elegans and mouse models are widely used to study NGLY1 function and deficiency, as they recapitulate key aspects of the human disease.
What are the potential therapeutic approaches for NGLY1 deficiency?
Current research explores gene therapy, small molecule chaperones, and dietary interventions, but no cure exists; model organisms are used to test these strategies.
Conclusion
Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity (GO:0000224) is a fundamental enzymatic function with broad implications in glycobiology, protein quality control, and human disease. From the bacterial PNGase F used in biotechnology to the human NGLY1 enzyme critical for ERAD, this activity is essential for understanding how cells manage glycoproteins. The link between NGLY1 mutations and a severe neurodevelopmental disorder underscores its clinical relevance and the need for continued research. With advanced CRISPR tools and model systems, researchers are well positioned to uncover new details about this activity and to develop therapeutic strategies for related disorders.
References
- 1. Altmann F et al.. 1998. Characterisation of peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase A and its N-glycans.. Eur J Biochem 252(1):118-23 PMID: 9523720
- 2. Barsomian GD et al.. 1990. Cloning and expression of peptide-N4-(N-acetyl-beta-D-glucosaminyl)asparagine amidase F in Escherichia coli.. J Biol Chem 265(12):6967-72 PMID: 2182635
- 3. Suzuki T et al.. 2022. Ever-expanding NGLY1 biology.. J Biochem 171(2):141-143 PMID: 34969094
- 4. Berger S et al.. 1995. Endo-N-acetyl-beta-D-glucosaminidase and peptide-N4-(N-acetyl-glucosaminyl) asparagine amidase activities during germination of Raphanus sativus.. Phytochemistry 39(3):481-7 PMID: 7576449
- 5. Maia N et al.. 2022. Impaired catabolism of free oligosaccharides due to MAN2C1 variants causes a neurodevelopmental disorder.. Am J Hum Genet 109(2):345-360 PMID: 35045343
- 6. Lehrbach NJ. 2022. NGLY1: insights from Caenorhabditis elegans.. J Biochem 171(2):145-152 PMID: 34697631
- 7. Tarentino AL et al.. 1990. Molecular cloning and amino acid sequence of peptide-N4-(N-acetyl-beta-D-glucosaminyl)asparagine amidase from flavobacterium meningosepticum.. J Biol Chem 265(12):6961-6 PMID: 2182634
- 8. Kuhn P et al.. 1995. Active site and oligosaccharide recognition residues of peptide-N4-(N-acetyl-beta-D-glucosaminyl)asparagine amidase F.. J Biol Chem 270(49):29493-7 PMID: 7493989
